Get the Stockscreener App
9.44
2.18%
-0.21
After Hours:
9.51
0.07
+0.74%
Mind Medicine Inc stock is traded at $9.44, with a volume of 960.33K.
It is down -2.18% in the last 24 hours and down -7.00% over the past month.
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).
See More
Previous Close:
$9.65
Open:
$9.66
24h Volume:
960.33K
Relative Volume:
0.80
Market Cap:
$718.27M
Revenue:
$11.40B
Net Income/Loss:
$-95.73M
P/E Ratio:
-3.8531
EPS:
-2.45
Net Cash Flow:
$-64.37M
1W Performance:
+2.39%
1M Performance:
-7.00%
6M Performance:
+46.36%
1Y Performance:
+52.75%
1-Day Range:
$9.36
$9.69
1-Week Range:
$9.07
$9.95
52-Week Range:
$4.70
$11.02
Mind Medicine Inc Stock (MNMD) Company Profile
Name
Mind Medicine Inc
Sector
Industry
Phone
212-220-6633
Address
ONE WORLD TRADE CENTER, NEW YORK
Compare MNMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MNMD
Mind Medicine Inc
|
9.44 | 709.90M | 11.40B | -95.73M | -64.37M | -2.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-04-25 | Resumed | Oppenheimer | Outperform |
| Jan-28-25 | Initiated | Evercore ISI | Outperform |
| Dec-20-24 | Initiated | Chardan Capital Markets | Buy |
| Oct-14-24 | Resumed | Leerink Partners | Outperform |
| Jul-24-24 | Initiated | ROTH MKM | Buy |
| May-29-24 | Initiated | Robert W. Baird | Outperform |
| Apr-15-24 | Initiated | Leerink Partners | Outperform |
| Dec-05-23 | Initiated | Canaccord Genuity | Buy |
| Dec-09-22 | Resumed | ROTH Capital | Buy |
| Nov-16-22 | Initiated | RBC Capital Mkts | Outperform |
| Aug-26-22 | Initiated | Oppenheimer | Outperform |
| Aug-10-22 | Initiated | Cantor Fitzgerald | Overweight |
| May-04-22 | Initiated | ROTH Capital | Buy |
| Jun-28-21 | Initiated | Maxim Group | Buy |
View All
Mind Medicine Inc Stock (MNMD) Latest News
Mind Medicine at H.C. Wainwright: Strategic Insights on MM120 Trials - Investing.com
MindMed’s MM120 Shows Promise in Treating Generalized Anxiety Disorder - TipRanks
Aug Chart Watch: Is Mind Medicine (MindMed) Inc. stock suitable for long term investingWeekly Stock Analysis & Weekly Breakout Stock Alerts - Lancaster City Council
MindMed announces inducement grants - Medical Buyer
78,750 Stock Options: MindMed's Latest Employee Inducement Grants for Brain Health Innovation Team - Stock Titan
MindMed Announces New Employee Inducement Grants - Business Wire
Published on: 2025-09-08 21:39:10 - beatles.ru
RSI + MACD Show Convergence for Mind Medicine (MindMed) Inc.Market Sentiment Report & Daily Oversold Stock Bounce Ideas - beatles.ru
Technical Bounce Expected in Mind Medicine (MindMed) Inc. Next Week - beatles.ru
Ally Bridge Group NY LLC Acquires 59,868 Shares of Mind Medicine (MindMed) Inc. $MNMD - MarketBeat
Understanding Mind Medicine (MindMed) Inc.’s price movementTrade Exit Summary & Stepwise Trade Signal Implementation - Newser
Mind Medicine’s LSD Dose Cuts Anxiety for 12 Weeks in Trial - WebProNews
PEAK6 LLC Lowers Holdings in Mind Medicine (MindMed) Inc. $MNMD - MarketBeat
Institutional Investors in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) See US$100m Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them. - 富途牛牛
Using Python tools to backtest Mind Medicine (MindMed) Inc. strategiesMarket Trend Summary & Reliable Volume Spike Trade Alerts - Newser
Will Mind Medicine (MindMed) Inc. benefit from rate cuts2025 Historical Comparison & AI Forecast Swing Trade Picks - خودرو بانک
Key resistance and support levels for Mind Medicine (MindMed) Inc.Profit Target & Step-by-Step Trade Execution Guides - Newser
Can Mind Medicine (MindMed) Inc. hit a new high this monthMarket Activity Summary & Consistent Income Trade Recommendations - Newser
What is the earnings history of Mind Medicine (MindMed) Inc.2025 Key Highlights & Free Daily Entry Point Trade Alerts - خودرو بانک
What the charts say about Mind Medicine (MindMed) Inc. todayWeekly Volume Report & Real-Time Market Sentiment Reports - Newser
Wellington Management Group LLP Has $1.32 Million Stock Position in Mind Medicine (MindMed) Inc. $MNMD - MarketBeat
How sentiment analysis helps forecast Mind Medicine (MindMed) Inc.2025 Analyst Calls & Fast Moving Market Watchlists - Newser
Can you recover from losses in Mind Medicine (MindMed) Inc.Inflation Watch & Weekly Stock Breakout Alerts - Newser
Mind Medicine (MindMed) Inc. stock outlook for YEAR2025 Biggest Moves & AI Powered Market Entry Strategies - Newser
When is the best time to exit Mind Medicine (MindMed) Inc.2025 Institutional Moves & Fast Momentum Stock Entry Tips - Newser
Intraday pattern recognizer results for Mind Medicine (MindMed) Inc.July 2025 Short Interest & Verified High Yield Trade Plans - Newser
Mind Medicine’s Breakthrough in Anxiety Disorder Treatment - TipRanks
Journal of the American Medical Association (JAMA) Publishes Results from First-Ever Randomized, Placebo-Controlled Clinical Trial Assessing the Dose-Dependent Efficacy of MM120 (Lysergide D-Tartrate, LSD) in Generalized Anxiety Disorder (GAD) | Fina - FinancialContent
Is Mind Medicine (MindMed) Inc. reversing from oversold territoryMarket Performance Summary & Advanced Technical Signal Analysis - Newser
Full technical analysis of Mind Medicine (MindMed) Inc. stockWeekly Trade Analysis & Reliable Entry Point Alerts - Newser
Charles Schwab Investment Management Inc. Reduces Stock Position in Mind Medicine (MindMed) Inc. $MNMD - MarketBeat
Highs Report: Is Mind Medicine (MindMed) Inc. stock undervalued right nowTake Profit & Free Daily Entry Point Trade Alerts - خودرو بانک
Price momentum metrics for Mind Medicine (MindMed) Inc. explainedQuarterly Performance Summary & Precise Swing Trade Alerts - Newser
What institutional flow reveals about Mind Medicine (MindMed) IncGlobal Markets & Weekly Momentum Stock Picks - Newser
Will Mind Medicine (MindMed) Inc. announce a stock splitTrade Ideas & Weekly High Potential Stock Alerts - خودرو بانک
Can Mind Medicine (MindMed) Inc. expand into new marketsWeekly Trend Summary & Daily Technical Forecast Reports - خودرو بانک
How moving averages guide Mind Medicine (MindMed) Inc. tradingJuly 2025 Trends & Safe Entry Zone Tips - Newser
Candlestick signals on Mind Medicine (MindMed) Inc. stock todayTrade Risk Report & Daily Stock Trend Reports - Newser
Machine Learning Models Forecast Mind Medicine (MindMed) Inc. UptickGDP Growth & Low Risk Growth Stock Ideas - beatles.ru
Ranking Mind Medicine (MindMed) Inc. among high performing stocks via toolsJobs Report & Verified Chart Pattern Signals - Newser
What moving averages say about Mind Medicine (MindMed) Inc.Quarterly Trade Summary & Trade Opportunity Analysis Reports - Newser
Is Mind Medicine (MindMed) Inc. stock entering bullish territoryJuly 2025 Decliners & Free Daily Entry Point Trade Alerts - Newser
Mind Medicine (MindMed) Inc. stock trend outlook and recovery pathTrade Performance Summary & AI Driven Stock Reports - Newser
Trend analysis for Mind Medicine (MindMed) Inc. this weekJuly 2025 Sentiment & Community Verified Trade Alerts - Newser
Published on: 2025-09-03 03:12:47 - Newser
Mind Medicine (MindMed) Inc. stock retracement – recovery analysis2025 Market WrapUp & Community Trade Idea Sharing - Newser
Using flow based indicators on Mind Medicine (MindMed) Inc.Quarterly Portfolio Report & AI Forecast for Swing Trade Picks - Newser
What candlestick patterns are forming on Mind Medicine (MindMed) Inc.Market Rally & Verified Momentum Stock Watchlist - Newser
Is Mind Medicine (MindMed) Inc. forming a bottoming baseM&A Rumor & Real-Time Volume Trigger Notifications - Newser
Published on: 2025-09-02 23:36:30 - Newser
Mind Medicine Inc Stock (MNMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):